Antiparasitic 70288-86-7 Ivermectin Raw Material Ivermectin

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: QS-Ivermectin
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: White Powder
• Purity: >99%
• Product Name: Ivermectin
• Name: Ivermectin Powder
• Appearance: White Powder
• Color: White
• Specific: COA
• Grade: Pharmaceutical Grade
• Application: Pharmaceutical
• Assay: 99%
• Test Method: HPLC
• CAS No: 70288-86-7
• Logp: 5.60140
• Mf: C48h74o14
• MW: 875.09300
• Einecs No: 274-536-0
• Melting Point: 157ºC
• Transport Package: Negotiable
• Specification: 99%
• Trademark: QS-Ivermectin
• Origin: Shaanxi Xi′an
• Production Capacity: 2000kg/Month

Product Description

Antiparasitic 70288-86-7 Ivermectin Raw Material Ivermectin 

Product Description

Product Details

Product name	Ivermectin
Cas number	70288-86-7
Apperance	White Powder
MF	C48H74O14
MW	875.09300

Ivermectin is a new type of broad-spectrum, highly efficient, and low toxicity antibiotic antiparasitic drug, which has good killing effects on parasites, especially nematodes and arthropods, both inside and outside the body. But it is ineffective against tapeworms, flukes, and protozoa. The killing effect of macrolide antiparasitic drugs on nematodes and arthropods is to increase the release of the inhibitory neurotransmitter gamma aminobutyric acid (GABA) in the parasite, as well as to open the glutamate controlled Cl ion channel, enhance the permeability of the nerve membrane to Cl, thereby blocking the transmission of nerve signals, ultimately leading to nerve paralysis, causing muscle cells to lose their ability to contract, resulting in the death of the parasite.

Application&Function

It is a derivative of avermectin. The discoverers of avermectin, William C. Campbell and Satoshi Omura, were awarded the 2015 Nobel Prize in Physiology or Medicine for their outstanding achievements in combating river blindness and elephantiasis with their derivative, ivermectin.
Ivermectin is a semi synthetic macrolide multi-component antibiotic produced by fermentation of Streptomyces avermitilis. The main content of ivermectin B1 (Bla+B1b) should not be less than 93%, with Bla not less than 85%.
Ivermectin B1, also known as 22,23-dihydroavermectin B1.

Specification